6American Society of Health-System Pharmacists.Top-pri-ority actions for preventing adverse drug events in hospitals [J]. Am J Hosp Pharm, 1993, 50:305.
7Alan JF, Roland BH, Michael GT. Pharmacist surveillance of adverse drug events [J]. Am J Health-Syst Pharm,2004, 61(14):1466.
8Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993[J]. Lancet,1998, 351:643.
9Classen DC, Pestontnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: Excess length of stay,extra costs, and attributable mortality[J]. JAMA, 1997,277(4):301.
1G. Berg,F. Steveninck,J. M. Gubbens-Stibbe,H. C. Schoemaker,A. G. Boer,A. F. Cohen. Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers[J] 1990,European Journal of Clinical Pharmacology(3):315～316
